Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,364 public trials 203 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Recruiting

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

NCT07630545

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +19 more
Locations
  • The Royal Adelaide Hospital Adelaide, Australia
  • Doherty Clinical Trials Melbourne, Australia
  • Monash Health, Kingston Centre Melbourne, Australia
  • Centre Hospitalier Universitaire de Lille, Institut Cœur Poumon Lille, France
View all 18 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

NCT06860594

Conditions
Astrocytoma, Astrocytoma, IDH-Mutant, Grade 2, Glioblastoma, +22 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 43 locations
View Trial Details
Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

NCT06549595

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Huntsville, Alabama, United States
  • Research Site Anchorage, Alaska, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Clovis, California, United States
View all 228 locations
View Trial Details
Recruiting

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT05006716

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +37 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
View all 115 locations
View Trial Details
Recruiting

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

NCT07422610

Conditions
Advanced Malignancies and Hepatic Impairment, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Saint-Herblain, France
  • Novartis Investigative Site Candiolo, TO, Italy
  • Novartis Investigative Site Pozuelo de Alarcón, Madrid, Spain
View Trial Details
Recruiting

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

NCT07519772

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Colorado Blood Cancer Institute ( Site 7000) Denver, Colorado, United States
  • SCRI Oncology Partners ( Site 0100) Nashville, Tennessee, United States
  • Instituto Alexander Fleming ( Site 1404) Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Sanatorio Nuestra Senora del Rosario ( Site 1403) Rosario, Santa Fe Province, Argentina
View all 34 locations
View Trial Details
Recruiting

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

NCT07634471

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • SCRI Oncology Partners ( Site 7000) Nashville, Tennessee, United States
  • Hadassah Medical Center ( Site 0701) Jerusalem, Israel
  • Sheba Medical Center ( Site 0702) Ramat Gan, Israel
  • Sourasky Medical Center ( Site 0704) Tel Aviv, Israel
View all 17 locations
View Trial Details
Recruiting

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

NCT06149286

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Boca Raton Clinical Research (BRCR) Global Plantation, Florida, United States
  • Indiana University and Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Hattiesburg Clinic Hattiesburg, Mississippi, United States
View all 171 locations
View Trial Details

Related conditions